Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
Preemptive Therapy for High Risk Chronic Lymphoid Leukemia Stage AHemic and Lymphatic Diseases, Leukemia, B-Cell, Neoplasms by Histologic Type, hematologic disorder, immune system disorder, immunoproliferative disorder, leukemia, lymphatic system disorder, lymphoid leukemia, lymphoproliferative syndrome, neoplasmActive, not recruitingPhase 22025-11-26NCT03766763

1 results · Page 1 of 1

Swipe the table sideways for more columns.

OrganizationsLinked trials
French Innovative Leukemia Organisation17

23 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sitesCityCountryLinked trials
Bordeaux PessacPessacFrance5
Centre Henri Becquerel - Service Hématologie CliniqueRouenFrance3
Centre Hospitalier Lyon SudPierre-BéniteFrance51
Centre Hospitalier Regional Metz ThionvilleMetzFrance2
Centre Leon BerardLyonFrance70
Ch AnnecyAnnecyFrance1
Ch BeziersBéziersFrance2
CH BLOISBloisFrance1
CH Cote BasqueBayonneFrance3
Chd Le MansLe MansFrance2
CHD VendeeLa Roche-sur-YonFrance9
CHU AmiensAmiensFrance47
CHU AngersAngersFrance48
CHU caenCaenFrance18
Chu CreteilCréteilFrance1
CHU EstaingClermont-FerrandFrance6
CHU GrenobleGrenobleFrance19
Hopital HuriezLilleFrance2
Hopitaljean MinjozBesançonFrance1
Hôpital Bretonneau - Hématologie et Thérapie CellulaireToursFrance3
Hôpital privé SévignéCesson-SévignéFrance5
Institut BergonieBordeauxFrance53
Institut Paoli CalmetteMarseilleFrance2